High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: A multicentre GEFPICS study
Authors:
- Magali Lacroix-TrikiMLMagali Lacroix-Triki
- Simone Mathoulin-PelissierSMSimone Mathoulin-Pelissier
- Jean-Pierre GhnassiaJGJean-Pierre Ghnassia
- Gaetan MacgroganGMGaetan Macgrogan
- Anne Vincent-SalomonAVAnne Vincent-Salomon
- Véronique BrousteVBVéronique Brouste
- Marie-Christine MathieuMMMarie-Christine Mathieu
- Pascal RogerPRPascal Roger
- Frédéric BibeauFBFrédéric Bibeau
- Jocelyne JacquemierJJJocelyne Jacquemier
- Frédérique Penault-LlorcaFPFrédérique Penault-Llorca
- Laurent ArnouldLALaurent Arnould
- 1 November 2006
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 42 (17) , 2946-2953
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized TrialJournal of Clinical Oncology, 2001
- HER-2 and topo-isomerase IIα as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamideAnnals of Oncology, 2001
- HER2 and Choice of Adjuvant Chemotherapy for Invasive Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15JNCI: Journal of the National Cancer Institute, 2000
- Strong Correlation between Results of Fluorescent In Situ Hybridization and Immunohistochemistry for the Assessment of the ERBB2 (HER-2/neu) Gene Status in Breast CarcinomaLaboratory Investigation, 2000
- HER-2/neu Protein Expression in Breast Cancer Evaluated by ImmunohistochemistryAmerican Journal of Clinical Pathology, 2000
- Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ HybridizationLaboratory Investigation, 2000
- Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry for the Evaluation of HER-2/neu in Breast CancerJournal of Clinical Oncology, 1999
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987